XML 79 R59.htm IDEA: XBRL DOCUMENT
v3.26.1

Expected credit losses on financial assets and reconciliation of carrying amount (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2025
Disclosure of fair value measurement of assets [abstract] |
Expected Credit Losses on Financial Assets and Reconciliation of carrying amount | It is presented below the reconciliation of gross carrying amount of financial assets through other comprehensive income and financial assets measured at amortized cost – that have their ECLs (Expected Credit Losses) measured using the three-stage model and the low credit risk simplification.
Stage 1 |  | Balance at December 31, 2024 |  | Acquisition / (Settlements) |  |  |  | Transfer to stage 2 |  | Transfer to stage 3 |  | Transfer from stage 2 |  | Transfer from stage 3 |  | Write-Off |  | Closing balance December 31, 2025
Financial assets at fair value through other comprehensive income |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Securities |  | 53,250,910 |  |  | (11,027,561) |  |  |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 42,223,349 |
Financial assets amortized cost |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Securities |  | 2,850,108 |  |  | 4,585,816 |  |  |  |  | (1,103) |  |  | (74,197) |  |  | — |  |  | — |  |  | — |  |  | 7,360,624 |
Securities purchased under resale agreements |  | 22,059,501 |  |  | (4,993,837) |  |  |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 17,065,664 |
Loans and credit card operations |  | 26,337,288 |  |  | 5,949,078 |  |  |  |  | (1,302,940) |  |  | (538,578) |  |  | 1,603,609 |  |  | 3,171 |  |  | — |  |  | 32,051,628 |
Total on-balance exposures |  | 104,497,807 |  |  | (5,486,504) |  |  |  |  | (1,304,043) |  |  | (612,775) |  |  | 1,603,609 |  |  | 3,171 |  |  | — |  |  | 98,701,265 |
Off-balance exposures (credit card limits) |  | 7,473,577 |  |  | 293,552 |  |  |  |  | (518,677) |  |  | (12,458) |  |  | 137,723 |  |  | 3 |  |  | — |  |  | 7,373,720 |
Total exposures |  | 111,971,384 |  |  | (5,192,952) |  |  |  |  | (1,822,720) |  |  | (625,233) |  |  | 1,741,332 |  |  | 3,174 |  |  | — |  |  | 106,074,985 |
Stage 2 |  | Balance at December 31, 2024 |  | Acquisition / (Settlements) |  |  |  | Transfer to stage 1 |  | Transfer to stage 3 |  | Transfer from stage 1 |  | Transfer from stage 3 |  | Write-Off |  | Closing balance December 31, 2025
Financial assets amortized cost |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Securities |  | — |  |  | — |  |  |  |  | — |  |  | — |  |  | 1,103 |  |  | — |  |  | — |  |  | 1,103 |
Loans and credit card operations |  | 2,910,045 |  |  | (585,008) |  |  |  |  | (1,603,609) |  |  | (154,591) |  |  | 1,302,940 |  |  | 458 |  |  | — |  |  | 1,870,235 |
Total on-balance exposures |  | 2,910,045 |  |  | (585,008) |  |  |  |  | (1,603,609) |  |  | (154,591) |  |  | 1,304,043 |  |  | 458 |  |  | — |  |  | 1,871,338 |
Off-balance exposures (credit card limits) |  | 394,416 |  |  | (144,817) |  |  |  |  | (137,723) |  |  | (941) |  |  | 518,677 |  |  | 2 |  |  | — |  |  | 629,614 |
Total exposures |  | 3,304,461 |  |  | (729,825) |  |  |  |  | (1,741,332) |  |  | (155,532) |  |  | 1,822,720 |  |  | 460 |  |  | — |  |  | 2,500,952 |
Stage 3 |  | Balance at December 31, 2024 |  | Acquisition / (Settlements) |  |  |  | Transfer to stage 1 |  | Transfer to stage 2 |  | Transfer from stage 1 |  | Transfer from stage 2 |  | Write-Off |  | Closing balance December 31, 2025
Financial assets amortized cost |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Securities |  | — |  |  | — |  |  |  |  | — |  |  | — |  |  | 74,197 |  |  | — |  |  | — |  |  | 74,197 |
Securities purchased under resale agreements |  | — |  |  | — |  |  |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Loans and credit card operations |  | 401,211 |  |  | (129,631) |  |  |  |  | (3,171) |  |  | (458) |  |  | 538,578 |  |  | 154,591 |  |  | (264,955) |  |  | 696,165 |
Total on-balance exposures |  | 401,211 |  |  | (129,631) |  |  |  |  | (3,171) |  |  | (458) |  |  | 612,775 |  |  | 154,591 |  |  | (264,955) |  |  | 770,362 |
Off-balance exposures (credit card limits) |  | 5,558 |  |  | (5,769) |  |  |  |  | (3) |  |  | (2) |  |  | 12,458 |  |  | 941 |  |  | — |  |  | 13,183 |
Total exposures |  | 406,769 |  |  | (135,400) |  |  |  |  | (3,174) |  |  | (460) |  |  | 625,233 |  |  | 155,532 |  |  | (264,955) |  |  | 783,545 |
Consolidated Stages |  | Balance at December 31, 2024 |  |  |  | Purchases / (Settlements) |  |  |  | Write-Off |  | Closing balance December 31, 2025
Financial assets at fair value through other comprehensive income |  |  |  |  |  |  |  |  |  |  |  |
Securities |  | 53,250,910 |  |  |  |  | (11,027,561) |  |  |  |  | — |  |  | 42,223,349 |
Financial assets amortized cost |  |  |  |  |  |  |  |  |  |  |  |
Securities |  | 2,850,108 |  |  |  |  | 4,585,816 |  |  |  |  | — |  |  | 7,435,924 |
Securities purchased under resale agreements |  | 22,059,501 |  |  |  |  | (4,993,837) |  |  |  |  | — |  |  | 17,065,664 |
Loans and credit card operations |  | 29,648,544 |  |  |  |  | 5,234,439 |  |  |  |  | (264,955) |  |  | 34,618,028 |
Total on-balance exposures |  | 107,809,063 |  |  |  |  | (6,201,143) |  |  |  |  | (264,955) |  |  | 101,342,965 |
Off-balance exposures (credit card limits) |  | 7,873,551 |  |  |  |  | 142,966 |  |  |  |  | — |  |  | 8,016,517 |
Total exposures |  | 115,682,614 |  |  |  |  | (6,058,177) |  |  |  |  | (264,955) |  |  | 109,359,482 |
Stage 1 |  | Balance at December 31, 2023 |  | Acquisition / (Settlements) |  | Transfer to stage 2 |  | Transfer to stage 3 |  | Transfer from stage 2 |  | Transfer from stage 3 |  | Write-Off |  | Closing balance December 31, 2024
Financial assets at fair value through other comprehensive income |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Securities |  | 43,693,837 |  |  | 9,557,073 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 53,250,910 |
Financial assets amortized cost |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Securities |  | 6,861,493 |  |  | (4,011,385) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 2,850,108 |
Securities purchased under resale agreements |  | 14,891,781 |  |  | 7,167,720 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 22,059,501 |
Loans and credit card operations |  | 26,447,368 |  |  | 1,597,545 |  |  | (2,108,966) |  |  | (309,713) |  |  | 710,801 |  |  | 253 |  |  | — |  |  | 26,337,288 |
Total on-balance exposures |  | 91,894,479 |  |  | 14,310,953 |  |  | (2,108,966) |  |  | (309,713) |  |  | 710,801 |  |  | 253 |  |  | — |  |  | 104,497,807 |
Off-balance exposures (credit card limits) |  | 8,323,897 |  |  | (716,113) |  |  | (300,426) |  |  | (206) |  |  | 166,424 |  |  | 1 |  |  | — |  |  | 7,473,577 |
Total exposures |  | 100,218,376 |  |  | 13,594,840 |  |  | (2,409,392) |  |  | (309,919) |  |  | 877,225 |  |  | 254 |  |  | — |  |  | 111,971,384 |
Stage 2 |  | Balance at December 31, 2023 |  | Acquisition / (Settlements) |  | Transfer to stage 1 |  | Transfer to stage 3 |  | Transfer from stage 1 |  | Transfer from stage 3 |  | Write-Off |  | Closing balance December 31, 2024
Financial assets amortized cost |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Loans and credit card operations |  | 2,202,931 |  |  | (566,369) |  |  | (710,801) |  |  | (125,492) |  |  | 2,108,966 |  |  | 810 |  |  | — |  |  | 2,910,045 |
Total on-balance exposures |  | 2,202,931 |  |  | (566,369) |  |  | (710,801) |  |  | (125,492) |  |  | 2,108,966 |  |  | 810 |  |  | — |  |  | 2,910,045 |
Off-balance exposures (credit card limits) |  | 583,270 |  |  | (322,731) |  |  | (166,424) |  |  | (130) |  |  | 300,426 |  |  | 5 |  |  | — |  |  | 394,416 |
Total exposures |  | 2,786,201 |  |  | (889,100) |  |  | (877,225) |  |  | (125,622) |  |  | 2,409,392 |  |  | 815 |  |  | — |  |  | 3,304,461 |
Stage 3 |  | Balance at December 31, 2023 |  | Acquisition / (Settlements) |  | Transfer to stage 1 |  | Transfer to stage 2 |  | Transfer from stage 1 |  | Transfer from stage 2 |  | Write-Off |  | Closing balance December 31, 2024
Financial assets amortized cost |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Loans and credit card operations |  | 231,590 |  |  | (80,172) |  |  | (253) |  |  | (810) |  |  | 309,713 |  |  | 125,492 |  |  | (184,349) |  |  | 401,211 |
Total on-balance exposures |  | 231,590 |  |  | (80,172) |  |  | (253) |  |  | (810) |  |  | 309,713 |  |  | 125,492 |  |  | (184,349) |  |  | 401,211 |
Off-balance exposures (credit card limits) |  | 5,540 |  |  | (312) |  |  | (1) |  |  | (5) |  |  | 206 |  |  | 130 |  |  | — |  |  | 5,558 |
Total exposures |  | 237,130 |  |  | (80,484) |  |  | (254) |  |  | (815) |  |  | 309,919 |  |  | 125,622 |  |  | (184,349) |  |  | 406,769 |
Consolidated Stages |  | Balance at December 31, 2023 |  |  |  | Purchases / (Settlements) |  |  |  | Write-Off |  | Closing balance December 31, 2024
Financial assets at fair value through other comprehensive income |  |  |  |  |  |  |  |  |  |  |  |
Securities |  | 43,693,837 |  |  |  |  | 9,557,073 |  |  |  |  | — |  |  | 53,250,910 |
Financial assets amortized cost |  |  |  |  |  |  |  |  |  |  |  |
Securities |  | 6,861,493 |  |  |  |  | (4,011,385) |  |  |  |  | — |  |  | 2,850,108 |
Securities purchased under resale agreements |  | 14,891,781 |  |  |  |  | 7,167,720 |  |  |  |  | — |  |  | 22,059,501 |
Loans and credit card operations |  | 28,881,889 |  |  |  |  | 951,004 |  |  |  |  | (184,349) |  |  | 29,648,544 |
Total on-balance exposures |  | 94,329,000 |  |  |  |  | 13,664,412 |  |  |  |  | (184,349) |  |  | 107,809,063 |
Off-balance exposures (credit card limits) |  | 8,912,707 |  |  |  |  | (1,039,156) |  |  |  |  | — |  |  | 7,873,551 |
Total exposures |  | 103,241,707 |  |  |  |  | 12,625,256 |  |  |  |  | (184,349) |  |  | 115,682,614 |
The following table presents the gross carrying amount of financial assets measured at amortized cost, which have their ECLs measured using the simplified approach:
Gross Carrying Amount |  | 2025 |  | 2024
Securities trading and intermediation |  | 6,446,868 |  |  | 6,635,969 |
Accounts receivable |  | 1,489,842 |  |  | 854,828 |
Other financial assets |  | 16,933,883 |  |  | 13,257,189 |
Total |  | 24,870,593 |  |  | 20,747,986 |
Disclosure of Expected credit losses | The table below presents the changes in ECLs, measured according to the three-stage model, for assets classified as financial assets through other comprehensive income and financial assets measured at amortized cost in the period ended December 31, 2025 and December 31, 2024, segregated by stages:
Stage 1 |  | Balance at December 31, 2024 |  | Acquisition / (Settlements) |  |  |  | Transfer to stage 2 |  | Transfer to stage 3 |  | Transfer from stage 2 |  | Transfer from stage 3 |  | Write-Off |  | Closing balance December 31, 2025
Financial assets at fair value through other comprehensive income |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Securities |  | 15,622 |  |  | (15,622) |  |  |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Financial assets amortized cost |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Securities |  | 13,962 |  |  | 15,030 |  |  |  |  | (17) |  |  | (12,250) |  |  | — |  |  | — |  |  | — |  |  | 16,725 |
Securities purchased under resale agreements |  | 2,364 |  |  | 201 |  |  |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 2,565 |
Loans and credit card operations |  | 79,029 |  |  | 317,847 |  |  |  |  | (27,310) |  |  | (177,848) |  |  | 7,117 |  |  | 72 |  |  | — |  |  | 198,907 |
Total on-balance exposures |  | 110,977 |  |  | 317,456 |  |  |  |  | (27,327) |  |  | (190,098) |  |  | 7,117 |  |  | 72 |  |  | — |  |  | 218,197 |
Off-balance exposures (credit card limits) |  | 11,264 |  |  | (507) |  |  |  |  | (1,375) |  |  | (4,243) |  |  | 202 |  |  | — |  |  | — |  |  | 5,341 |
Total exposures |  | 122,241 |  |  | 316,949 |  |  |  |  | (28,702) |  |  | (194,341) |  |  | 7,319 |  |  | 72 |  |  | — |  |  | 223,538 |
Stage 2 |  | Balance at December 31, 2024 |  | Acquisition / (Settlements) |  |  |  | Transfer to stage 1 |  | Transfer to stage 3 |  | Transfer from stage 1 |  | Transfer from stage 3 |  | Write-Off |  | Closing balance December 31, 2025
Financial assets amortized cost |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Securities |  | — |  |  | — |  |  |  |  | — |  |  | — |  |  | 17 |  |  | — |  |  | — |  |  | 17 |
Loans and credit card operations |  | 87,885 |  |  | 47,859 |  |  |  |  | (7,117) |  |  | (110,526) |  |  | 27,310 |  |  | 23 |  |  | — |  |  | 45,434 |
Total on-balance exposures |  | 87,885 |  |  | 47,859 |  |  |  |  | (7,117) |  |  | (110,526) |  |  | 27,327 |  |  | 23 |  |  | — |  |  | 45,451 |
Off-balance exposures (credit card limits) |  | 7,804 |  |  | (7,707) |  |  |  |  | (202) |  |  | (60) |  |  | 1,375 |  |  | — |  |  | — |  |  | 1,210 |
Total exposures |  | 95,689 |  |  | 40,152 |  |  |  |  | (7,319) |  |  | (110,586) |  |  | 28,702 |  |  | 23 |  |  | — |  |  | 46,661 |
Stage 3 |  | Balance at December 31, 2024 |  | Acquisition / (Settlements) |  |  |  | Transfer to stage 1 |  | Transfer to stage 2 |  | Transfer from stage 1 |  | Transfer from stage 2 |  | Write-Off |  | Closing balance December 31, 2025
Financial assets amortized cost |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Securities |  | — |  |  | — |  |  |  |  | — |  |  | — |  |  | 12,250 |  |  | — |  |  | — |  |  | 12,250 |
Securities purchased under resale agreements |  | — |  |  | — |  |  |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Loans and credit card operations |  | 230,080 |  |  | (32,647) |  |  |  |  | (72) |  |  | (23) |  |  | 177,848 |  |  | 110,526 |  |  | (264,955) |  |  | 220,757 |
Total on-balance exposures |  | 230,080 |  |  | (32,647) |  |  |  |  | (72) |  |  | (23) |  |  | 190,098 |  |  | 110,526 |  |  | (264,955) |  |  | 233,007 |
Off-balance exposures (credit card limits) |  | 4,019 |  |  | (4,028) |  |  |  |  | — |  |  | — |  |  | 4,243 |  |  | 60 |  |  | — |  |  | 4,294 |
Total exposures |  | 234,099 |  |  | (36,675) |  |  |  |  | (72) |  |  | (23) |  |  | 194,341 |  |  | 110,586 |  |  | (264,955) |  |  | 237,301 |
Consolidated Stages |  | Balance at December 31, 2024 |  | Increase / (Reversal) |  |  |  | Write-Off |  | Closing balance December 31, 2025
Financial assets at fair value through other comprehensive income |  |  |  |  |  |  |  |  |  |
Securities |  | 15,622 |  |  | (15,622) |  |  |  |  | — |  |  | — |
Financial assets amortized cost |  |  |  |  |  |  |  |  |  |
Securities |  | 13,962 |  |  | 15,030 |  |  |  |  | — |  |  | 28,992 |
Securities purchased under resale agreements |  | 2,364 |  |  | 201 |  |  |  |  | — |  |  | 2,565 |
Loans and credit card operations |  | 396,994 |  |  | 333,059 |  |  |  |  | (264,955) |  |  | 465,098 |
Total on-balance exposures |  | 428,942 |  |  | 332,668 |  |  |  |  | (264,955) |  |  | 496,655 |
Off-balance exposures (credit card limits) |  | 23,087 |  |  | (12,242) |  |  |  |  | — |  |  | 10,845 |
Total exposures |  | 452,029 |  |  | 320,426 |  |  |  |  | (264,955) |  |  | 507,500 |
Stage 1 |  | Balance at December 31, 2023 |  | Acquisition / (Settlements) |  | Transfer to stage 2 |  | Transfer to stage 3 |  | Transfer from stage 2 |  | Transfer from stage 3 |  | Write-Off |  | Closing balance December 31, 2024
Financial assets at fair value through other comprehensive income |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Securities |  | 12,199 |  |  | 3,423 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 15,622 |
Financial assets amortized cost |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Securities |  | 6,072 |  |  | 7,890 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 13,962 |
Securities purchased under resale agreements |  | 2,803 |  |  | (439) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 2,364 |
Loans and credit card operations |  | 54,845 |  |  | 227,395 |  |  | (57,266) |  |  | (148,947) |  |  | 2,872 |  |  | 130 |  |  | — |  |  | 79,029 |
Total on-balance exposures |  | 75,919 |  |  | 238,269 |  |  | (57,266) |  |  | (148,947) |  |  | 2,872 |  |  | 130 |  |  | — |  |  | 110,977 |
Off-balance exposures (credit card limits) |  | 8,162 |  |  | 8,349 |  |  | (5,770) |  |  | (32) |  |  | 555 |  |  | — |  |  | — |  |  | 11,264 |
Total exposures |  | 84,081 |  |  | 246,618 |  |  | (63,036) |  |  | (148,979) |  |  | 3,427 |  |  | 130 |  |  | — |  |  | 122,241 |
Stage 2 |  | Balance at December 31, 2023 |  | Acquisition / (Settlements) |  | Transfer to stage 1 |  | Transfer to stage 3 |  | Transfer from stage 1 |  | Transfer from stage 3 |  | Write-Off |  | Closing balance December 31, 2024
Financial assets amortized cost |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Loans and credit card operations |  | 74,696 |  |  | 76,541 |  |  | (2,872) |  |  | (117,930) |  |  | 57,266 |  |  | 184 |  |  | — |  |  | 87,885 |
Total on-balance exposures |  | 74,696 |  |  | 76,541 |  |  | (2,872) |  |  | (117,930) |  |  | 57,266 |  |  | 184 |  |  | — |  |  | 87,885 |
Off-balance exposures (credit card limits) |  | 6,203 |  |  | (3,608) |  |  | (555) |  |  | (6) |  |  | 5,770 |  |  | — |  |  | — |  |  | 7,804 |
Total exposures |  | 80,899 |  |  | 72,933 |  |  | (3,427) |  |  | (117,936) |  |  | 63,036 |  |  | 184 |  |  | — |  |  | 95,689 |
Stage 3 |  | Balance at December 31, 2023 |  | Acquisition / (Settlements) |  | Transfer to stage 1 |  | Transfer to stage 2 |  | Transfer from stage 1 |  | Transfer from stage 2 |  | Write-Off |  | Closing balance December 31, 2024
Financial assets amortized cost |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Loans and credit card operations |  | 182,282 |  |  | (34,416) |  |  | (130) |  |  | (184) |  |  | 148,947 |  |  | 117,930 |  |  | (184,349) |  |  | 230,080 |
Total on-balance exposures |  | 182,282 |  |  | (34,416) |  |  | (130) |  |  | (184) |  |  | 148,947 |  |  | 117,930 |  |  | (184,349) |  |  | 230,080 |
Off-balance exposures (credit card limits) |  | 3,766 |  |  | 215 |  |  | — |  |  | — |  |  | 32 |  |  | 6 |  |  | — |  |  | 4,019 |
Total exposures |  | 186,048 |  |  | (34,201) |  |  | (130) |  |  | (184) |  |  | 148,979 |  |  | 117,936 |  |  | (184,349) |  |  | 234,099 |
Consolidated Stages |  | Balance at December 31, 2023 |  | Increase / (Reversal) |  |  |  | Write-Off |  | Closing balance December 31, 2024
Financial assets at fair value through other comprehensive income |  |  |  |  |  |  |  |  |  |
Securities |  | 12,199 |  |  | 3,423 |  |  |  |  | — |  |  | 15,622 |
Financial assets amortized cost |  |  |  |  |  |  |  |  |  |
Securities |  | 6,072 |  |  | 7,890 |  |  |  |  | — |  |  | 13,962 |
Securities purchased under resale agreements |  | 2,803 |  |  | (439) |  |  |  |  | — |  |  | 2,364 |
Loans and credit card operations |  | 311,823 |  |  | 269,520 |  |  |  |  | (184,349) |  |  | 396,994 |
Total on-balance exposures |  | 332,897 |  |  | 280,394 |  |  |  |  | (184,349) |  |  | 428,942 |
Off-balance exposures (credit card limits) |  | 18,131 |  |  | 4,956 |  |  |  |  | — |  |  | 23,087 |
Total exposures |  | 351,028 |  |  | 285,350 |  |  |  |  | (184,349) |  |  | 452,029 |
The table below presents the ECLs for the financial assets measured according to simplified approach in the period ended December 31, 2025 and 2024:
Expected Credit Losses |  | 2025 |  | 2024
Securities trading and intermediation |  | 147,384 |  |  | 136,872 |
Accounts receivable |  | 123,418 |  |  | 75,885 |
Other financial assets |  | 20,891 |  |  | 24,192 |
Total |  | 291,693 |  |  | 236,949 |
Disclosure of Expected credit loss segregated by product | The table below presents the expected credit losses for 2025 and 2024, segregated by products:
Expected Credit Losses |  | 2025 |  | 2024
Financial assets at fair value through other comprehensive income |  | — |  |  | 15,622 |
Securities |  | — |  |  | 15,622 |
Financial assets amortized cost |  | 788,348 |  |  | 650,269 |
Securities |  | 28,992 |  |  | 13,962 |
Securities purchased under resale agreements |  | 2,565 |  |  | 2,364 |
Loans and credit card operations |  | 465,098 |  |  | 396,994 |
Securities trading and intermediation |  | 147,384 |  |  | 136,872 |
Accounts receivable |  | 123,418 |  |  | 75,885 |
Other financial assets |  | 20,891 |  |  | 24,192 |
Total losses for exposures |  | 788,348 |  |  | 665,891 |
Off-balance exposures (credit card limits) |  | 10,845 |  |  | 23,087 |
Total exposures |  | 799,193 |  |  | 688,978 |

X
- Definition The disclosure of the credit risk exposure. Credit risk exposure is the credit risk inherent in an entity’s financial assets and commitments to extend credit. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 7 -IssueDate 2025-01-01 -Paragraph 35M -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_35M&doctype=Standard -URIDate 2025-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph 71 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_71&doctype=Standard -URIDate 2025-03-27 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph 71 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_71&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_DisclosureOfCreditRiskExposureExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ifrs-full_DisclosureOfFairValueMeasurementOfAssetsAbstract
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of Expected credit loss segregated by product + References No definition available. + Details
Name: | xp_DisclosureOfExpectedCreditLossSegregatedByProductTableTextBlock
Namespace Prefix: | xp_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of Expected credit losses + References No definition available. + Details
Name: | xp_DisclosureOfExpectedCreditLossesTableTextBlock
Namespace Prefix: | xp_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration